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Summary
 
B cells are susceptible to Fas ligand (FasL)
 
1
 
 CD4
 
1
 
 Th1 cell–mediated apoptosis. We demon-
strate that blocking the interactions between lymphocyte function associated (LFA)-1 and in-
tercellular adhesion molecule(ICAM)-1 and ICAM-2 completely suppresses Fas-dependent B
cell lysis. Antibodies to CD2 and CD48 partially suppress B cell apoptosis, whereas anti-B7.1
and anti-B7.2 antibodies have no effect. Also, B cells from ICAM-1–deficient mice are resis-
tant to FasL
 
1
 
 T cell–mediated death. Our results suggest that LFA-1/ICAM interactions are
crucial for Th1 cell–mediated B cell apoptosis and may contribute to the maintenance of B cell
homeostasis in vivo.
 
B
 
cells are sensitive to apoptosis mediated by Fas (Apo-
1/CD95; references 1–4). The importance of Fas in B
cell apoptosis is supported by B cell accumulation and au-
toantibody production in mice with defective Fas or Fas
ligand (FasL) genes or in humans with mutated Fas genes
(5–8). Although Fas–FasL interactions are important for T
cell apoptosis after TCR cross-linking, B cell apoptosis in-
duced by cross-linking of the B cell antigen receptor does
not involve Fas (9), suggesting that B and T cells differ in
Fas-dependent apoptosis. Since FasL expression is unde-
tectable in a variety of mouse and human B cell lines (9,
10), B cells are likely to depend on apoptotic signals
through Fas that are generated by interactions with FasL-
bearing T cells (11, 12).
Fas-mediated signaling in B cells appears to be regulated
by the cell activation status. While resting B cells resist Fas
cross-linking–induced death, mitogen-activated B cells are
susceptible to Fas-mediated killing (13). Cross-linking of
CD40 leads to upregulation of Fas expression and sensitiv-
ity to Fas-mediated apoptosis (14, 15). The roles of adhesion
molecules or accessory molecules have not been character-
ized in CD4
 
1
 
 T cell–mediated B cell lysis by the Fas pathway
(16). We examined the roles of accessory molecules in Fas-
mediated B cell lysis. We found that the interactions of
LFA-1 on CD4
 
1
 
 T cells and intercellular adhesion mole-
cule-1 and ICAM-2 on B cells are essential for the T cell–
mediated B cell lysis. Deficiency in ICAM-1 leads to de-
creased B cell apoptosis and the accumulation of B cells in
vivo.
 
Materials and Methods
 
Mice.
 
6–8-wk-old female C57BL/6, C57BL/6-ICAM-1
 
2
 
/
 
2
 
,
B10.A, and BALB/c mice were obtained from the Jackson Labo-
ratory (Bar Harbor, ME).
 
Antibodies, Fusion Proteins, and Peptides.
 
Anti–LFA-1 (M17.4),
anti–ICAM-1 (3E2), anti–ICAM-2 (MIC2/4), anti-B7.1 (1G10),
anti-B7.2 (GL1), anti-CD2 (RM2-5), anti-CD48 (HM48-1),
anti-Fas (Jo2), anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti–Thy-
1.2 (30-H12), anti-NK1.1 (PK136), anti-CD40 (3/12), anti-
FasL, anti-CD16/32, PE conjugated anti-Fas, PE-conjugated
anti–ICAM-1, PE-conjugated anti–ICAM-2, FITC-conjugated
anti–LFA-1, FITC- or PE-conjugated anti-CD4, and PE-conju-
gated anti-CD3 were purchased from PharMingen (San Diego,
CA). FITC-conjugated F(ab
 
9
 
)
 
2
 
 goat anti–mouse IgM was ob-
tained from CALTAG (South San Francisco, CA). Fas–Fc and
TNFR–Fc fusion proteins were gifts from Dr. D. Lynch (Immunex,
Seattle, WA). The pigeon cytochrome C peptide (amino acid res-
idues 88–104: KAERADLIAYLKQATAK) was synthesized by
the Peptide Synthesis Facility (National Institute of Allergy and
Infectious Diseases, National Institutes of Health, Bethesda, MD).
 
Purification and Stimulation of B Cells.
 
Mouse spleen cells were
suspended in RPMI 1640 medium containing 20% FCS (5 
 
3
 
 10
 
6
 
cells/ml) and 10 ml cells were added to each 100 mm tissue cul-
ture dish. After incubation at 37
 
8
 
C for 1 h, nonadherent cells
were recovered and resuspended in HBSS medium (10
 
7
 
/ml) con-
taining 10 
 
m
 
g/ml of anti–Thy-1.2, anti-CD4, anti-CD8, and
anti-NK1.1 antibodies, and then incubated on ice for 45 min.
Next, 1:10 low-tox-M rabbit complement (Accurate Chemical
and Science Corp., Westbury, NY) was added and the cells were
incubated at 37
 
8
 
C for 1 h. Live cells were purified by Ficoll gra-
dient separation and between 95 and 98% of the cells were posi-
tive for surface IgM when stained with a PE-conjugated F(ab
 
9
 
)
 
2
 
goat anti–mouse IgM (data not shown). The cells (10
 
6
 
 cells/ml)
were resuspended in RPMI 1640 medium with 10% FCS, 0.2
mM glutamine, 5 
 
3
 
 10
 
2
 
4
 
 M 
 
b
 
-mercaptoethanol (RPMI com-
plete medium) containing 100 
 
m
 
g/ml LPS, or 5 
 
m
 
g/ml anti-
CD40 and cultured at 37
 
8
 
C for 2 or 3 d before use.
 
Stimulation of T Cells and 
 
51
 
Cr-release Assay.
 
A.E7 T cells were
stimulated with antigen and IL-2 as previously described (17). To
induce allo-specific CD4
 
1
 
 T cells, BALB/c spleen cells were sus-
pended in RPMI complete medium containing 1 
 
m
 
g/ml FITC
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conjugated anti-CD4 (10
 
7
 
 cells/ml) and incubated on ice for 30
min. CD4
 
1
 
 cells were then purified with magnetic beads conju-
gated with sheep antifluorescein antibody (PerSeptive Diagnos-
tics, Cambridge, MA). The CD4
 
1
 
 T cells were mixed with 3,000
Rad-irradiated C57BL/6 mouse spleen cells at a ratio of 
 
z
 
1:5
and suspended in RPMI complete medium (10
 
6
 
 CD4
 
1
 
 T cells/
ml). After culture at 37
 
8
 
C for 5 d, live cells were purified and
used as effector cells to assay B cell lysis. For 
 
51
 
Cr-release assay, B
cells were incubated in RPMI medium containing 5% FCS (5 
 
3
 
10
 
6
 
/ml) and 200 
 
m
 
Ci/ml Na[
 
51
 
Cr]O
 
4
 
 (New England Nuclear,
Boston, MA) with or without 10 
 
m
 
m antigenic peptide at 37
 
8
 
C
for 1 h followed by washing with HBSS three times. The labeled
B cells (10
 
4
 
/well) were incubated with T cells in a total volume
of 200 
 
m
 
l in RPMI complete medium at various ratios in tripli-
cates in 96-well U-bottomed plates (Nunc, Roskilde, Denmark).
Various antibodies, isotype-matched antibody controls, Fas–Fc,
or TNFR–Fc fusion proteins at 10 
 
m
 
g/ml were added as indi-
cated. After 4 h incubation at 37
 
8
 
C, percentage cell loss was
quantitated as described (2).
 
Induction of B Cell Apoptosis with Anti-Fas.
 
B cells were sus-
pended in RPMI complete medium (0.5 
 
3
 
 10
 
6
 
 cells/ml) con-
taining 1 
 
m
 
g/ml of Jo2 (anti-Fas) or control hamster IgG. The
cells (10
 
5
 
/well) were cultured in 96-well flat-bottomed plates at
37
 
8
 
C for 24 h. Viable cells were quantitated and percentage of
cell loss was calculated as described previously (6).
 
Staining of Cell Surface Markers.
 
AE.7 cells were cultured in
RPMI complete medium (10
 
6
 
/ml) with or without 3,000 Rad-
irradiated B10A spleen cells (5 
 
3
 
 10
 
6
 
/ml) and 10 
 
m
 
M pigeon cy-
tochrome C peptide 88-104. A metalloproteinase inhibitor,
KBR8301 (18), was added to 10 
 
m
 
g/ml and the cells were cul-
tured at 37
 
8
 
C for 6 h. The cells were then stained with PE-conju-
gated anti-FasL and FITC-conjugated anti-CD4 followed by
flow cytometry. CD4
 
1
 
 AE7 cells were gated to analyze FasL ex-
pression. To examine the expression of accessory molecules, B
cells were blocked by incubating with 10 
 
m
 
g/ml anti-CD16/32,
1:100 normal rat serum, and 10 
 
m
 
g/ml normal hamster IgG on
ice for 30 min. The cells were next stained with 1 
 
m
 
g/ml PE-
conjugated anti-Fas, FITC-conjugated anti–LFA-1, PE-conjugated
anti–ICAM-1, or PE-conjugated anti–ICAM-2. Isotype-matched
FITC- or PE-conjugated rat anti-CD4 or PE-conjugated hamster
anti-CD3 were used as negative controls. After incubation on ice
for 30 min, the cells were analyzed by flow cytometry.
 
Results and Discussion
 
Fas-dependent and Antigen-specific Lysis of B Cells by CD4
 
1
 
T Cells.
 
We first tested the lysis of B cells by T cells in a
Th1-mediated cytotoxicity assay. We used either A.E7, a
CD4
 
1
 
 Th1 clone that recognizes pigeon cytochrome C
amino acids 88–104 presented by I-E
 
k
 
 (19), or allo-reactive
CD4
 
1
 
 T cells generated from an MLR. Resting B cells or
B cell blasts from either B10.A mice (I-E
 
k
 
1
 
) pulsed with
the pigeon cytochrome C peptide or B cells from C57BL/
6 mice were targets for A.E7 and the allo-reactive T cells,
respectively. We found that A.E7 cells efficiently lyse B cell
targets preactivated with either LPS or anti-CD40 but not
Figure 1. Lysis of B cells by
CD41 T cells. (A) Freshly iso-
lated resting B cells, and LPS- or
anti-CD40–activated B cells de-
rived from B10.A mice were la-
beled with 51Cr and pulsed with
antigen. A.E7 cells were mixed
with the labeled B cells for a 4 h
51Cr-release assay. (B) B cells de-
rived from B10.A mice were
stimulated with LPS and labeled
with 51Cr. A.E7 cells were mixed
with the labeled B cells for a 4 h
51Cr-release assay in the absence
or presence of 10 mg/ml anti-
CD4, anti-CD8, Fas–Fc, or
TNFR–Fc. (C) Freshly isolated
resting B cells, LPS- or anti-
CD40–activated B cells derived
from C57BL/6 mice were la-
beled with 51Cr. CD41 allo-reac-
tive CTL were mixed with the la-
beled B cells for a 4 h 51Cr-release
assay. (D) B cells derived from
C57BL/6 mice were stimulated
with LPS and labeled with 51Cr.
MLR-derived CD41 CTLs
were mixed with the labeled B
cells for a 4 h 51Cr-release assay
in the absence or presence of 10
mg/ml anti-CD4, anti-CD8,
Fas–Fc, or TNFR–Fc. The re-
sults are representatives of three
experiments and the results were
shown as average of triplicates
with standard deviation. 
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untreated resting B cells (Fig. 1 
 
A
 
). Blocking of Fas–FasL
interactions by Fas–Fc abolished the lysis of B cell targets
by A.E7 cells (Fig. 1 
 
B
 
), whereas TNFR–Fc, a blocker for
TNF action, did not interfere with B cell death (Fig. 1 
 
B
 
).
Similar results were obtained with allo-reactive CD4
 
1
 
 T
cells (Fig. 1, 
 
C
 
 and 
 
D
 
). These data agree with previous
findings that lysis of target B cells by CD4
 
1
 
 T cells is pre-
dominantly Fas dependent (2). Antigen-specific recogni-
tion by T cells is required because A.E7 cells failed to lyse
target B cells that were not pulsed with antigen before the
assay (reference 1 and data not shown). Thus, Th1-medi-
ated cytotoxicity against B cells is Fas and antigen depen-
dent.
 
Involvement of Accessory Molecules in Th1-mediated Lysis of
B Cells.
 
We next tested mAbs to block accessory mole-
cules in the T cell–mediated, B cell cytotoxicity assays. We
found that anti-LFA-1 completely blocked the killing of
target B cells by A.E7 (Fig. 2 
 
A
 
). Similar results were ob-
served with allo-reactive T cells. B cell lysis was also signif-
icantly suppressed by anti–ICAM-1 but not by anti–
ICAM-2 alone (Fig. 2, 
 
A
 
 and 
 
B
 
). Both anti–ICAM-1 and
anti–ICAM-2 together nearly completely suppressed B cell
apoptosis. Therefore, both ICAM-1 and ICAM-2 are in-
volved in T cell–mediated B cell killing, but ICAM-1 ap-
pears to be more important.
In contrast, blocking mAbs to B7.1 and B7.2 had no ef-
fect on B cell lysis by CD4
 
1
 
 T cells (Fig. 2, 
 
A
 
 and 
 
B
 
), al-
though CD28 and B7 molecules are highly expressed on
the T and B cells used in these assays (data not shown).
This indicates that the CD28/B7 interaction is not in-
volved in CD4
 
1
 
 T cell–mediated B cell killing. These re-
sults also suggest that the blocking of B cell lysis by other
antibodies is not simply a steric effect due to antibodies
bound to cell surface structures. We also examined CD2 on
T cells and CD48 on B cells, another receptor–ligand pair
important for T–B cell interactions in mice (20). We found
that B cell lysis was inhibited by anti-CD2 and anti-CD48
(Fig. 2, 
 
A
 
 and 
 
B
 
), but the effect was much weaker than by
blocking of LFA-1–ICAM interactions.
Our results suggested that their physical interaction, pos-
sibly by promoting Th1-B cell adhesion, was involved in
Th1-mediated B cell apoptosis. However, an alternative
possibility is that those mAbs may deliver a negative signal
into the cells and inhibit the killing process. We therefore
examined whether these mAbs influenced anti–Fas anti-
body–mediated B cell apoptosis. We first established condi-
tions in which anti–Fas antibody efficiently lysed the B cells
(Fig. 2 
 
C
 
). We then added anti–LFA-1, anti–ICAM-1,
anti–ICAM-2, anti-B7.1, anti-B7.2, anti-CD2, and anti-
CD48 and found that none of these affected direct anti-
Fas–mediated B cell lysis. Thus, these mAbs do not inter-
fere with apoptotic signaling from Fas.
It remained possible that LFA-1–ICAM interactions in
our assay simply promoted T cell activation and FasL ex-
pression rather than facilitate Fas–FasL interactions leading
to death. To distinguish between these possibilities, we
studied freshly activated A.E7 cells that express more FasL
to see if the requirement for LFA-1–ICAM interactions
was less. However, anti-LFA-1 and anti–ICAM-1 still
blocked B cell lysis by freshly activated A.E7 cells (Fig. 3).
Flow cytometry showed that FasL was upregulated on
AE.7 cells immediately after antigen stimulation (Fig. 3).
This supports the hypothesis that LFA-1 and ICAM function
primarily to promote T–B cell adhesion for Fas-mediated B
cell apoptosis. Although anti-Fas antibodies induce rapid
formation of a death-inducing signaling complex linked to
the cytoplasmic portion of Fas, proteolytic processing and
activation of FLICE/caspase 8 requires up to 20 min of
continuous Fas cross-linking (21). This suggests that the ac-
tivation of caspases essential for apoptosis requires certain
period of stabilized engagement of Fas receptor. It is there-
Figure 2. Inhibition of CD41 T cell–dependent lysis of B cells. (A) B
cells derived from B10.A mice were stimulated with LPS and labeled with
51Cr and pulsed with antigen. A.E7 cells were mixed with the labeled B
cells for a 4 h 51Cr-release assay in the absence or presence of 10 mg/ml
mAbs or control rat or hamster IgG. (B) B cells derived from C57BL/6
mice were stimulated with LPS and labeled with 51Cr. MLR-derived
CD41 CTLs were mixed with the labeled B cells for a 4 h 51Cr-release
assay in the absence or presence of 10 mg/ml mAbs or control rat or ham-
ster IgG. (C) LPS blasts prepared from C57BL/6 mice were resuspended
in RPMI complete medium (106 cells/ml) containing 1 mg/ml either
control hamster IgG or Jo2 antibody. The cells were added to 96-well
plates (200 ml/well) and 10 mg/ml of various mAbs or control rat or ham-
ster IgG were added to the cultures as indicated. After culture at 378C for
18 h, the cells were harvested and the recovery of viable cells and the per-
centage of cell loss was calculated. The results presented are representa-
tives of two experiments and the results were presented as average of trip-
licates with standard deviation.1174 Role of Intercellular Adhesion Molecule in B Cell Apoptosis
fore reasonable to postulate that LFA-1–ICAM binding
promotes Fas signaling by enhancing FasL–Fas interactions
between T and B cells.
Stimulation of B cells with LPS or CD40 ligation sensi-
tizes B cells for Fas-mediated apoptosis. This is at least par-
tially due to Fas upregulation. Fig. 4 shows that both LPS
and anti-CD40 upregulated Fas as they sensitized B cells for
apoptosis. Concomitant with the sensitization for apoptosis,
we found that LPS and anti-CD40 induced significant up-
regulation of ICAM-1 on B cells, whereas LFA-1 was
slightly increased and ICAM-2 was not changed at all.
Thus, the induction of both Fas and ICAM-1 on B cells by
stimuli such as LPS and anti-CD40 may make B cells vul-
nerable to apoptosis mediated by FasL1 T cells.
Resistance of B Cells from ICAM-1 Knockout Mice to Th1-
mediated Lysis. We also tested the cytotoxic effect of
MLR-derived CD41 T cells on B cells prepared from mice
homozygously deficient for ICAM-1. Wild-type and
ICAM-12/2 B cells express similar levels of Fas (data not
shown). However, LPS- or anti-CD40–stimulated B cells
from ICAM-12/2 mice are not efficiently lysed (Fig. 5).
These data support the concept that it is LFA-1 on Th1
cells and ICAM-1 on B cells that are crucial for apoptosis.
However, the deficiency of ICAM-1 on B cells did not
completely block killing. This raised the possibility that
ICAM-2 (22) could promote T–B adhesion in the absence
of ICAM-1. Alternatively, the residual killing of ICAM-
12/2 B cells could result from the binding of LFA-1 on B
cells to ICAM-1 on T cells. Additional assays with ICAM-
1–deficient B cells enabled us to examine these possibilities.
The addition of anti–ICAM-1 did not further reduce the
killing of ICAM-12/2 B cells (Fig. 6). By contrast, anti–
ICAM-2 alone completely blocked B cell lysis. This argues
that the interaction of LFA-1 on the B cells with ICAM-1
on the Th1 cells does not play a significant role in T–B cell
interactions. Rather ICAM-1, and to some degree ICAM-
2, on B cells interacting with LFA-1 on T cells appear to be
crucial for Fas-mediated B cell killing. Why the interaction
of LFA-1 on B cells and ICAM-1 on T cells is not required
is unclear, although flow cytometry reveals their abundant
Figure 3. Suppression of activated AE.7-mediated lysis of B cells. AE.7
cells without (A) or with (C) further stimulation by B10A spleen cells plus
antigen for 6 h were purified by Ficoll gradient separation. The AE.7 cells
were then mixed with 51Cr-labeled B10A B cells pulsed with antigen for
a 4 h 51Cr-release assay. For FasL staining, AE.7 cells were cultured in RPMI
complete medium containing 10 mg/ml KBR8301 without (B) or with
(D) the stimulation by B10A spleen cells plus antigen and were purified
by Ficoll gradient separation. The cells were either stained with FITC-
conjugated anti-CD4 with (solid line) or without (dotted line) PE-conju-
gated anti-FasL, and analyzed by flow cytometry. Live CD41 AE.7 cells
were gated for analysis. The results are representatives of two experiments.
Figure 4. Staining of Fas,
LFA-1, ICAM-1, and ICAM-2
on B cells. Freshly purified B
cells and LPS- or anti-CD40–
stimulated B cells were stained
with 1 mg/ml PE-conjugated
anti-Fas, FITC-conjugated anti–
LFA-1, PE-conjugated anti–
ICAM-1, or PE-conjugated
anti–ICAM-2. Isotype-matched
FITC- or PE-conjugated rat
anti-CD4 or PE-conjugated
hamster anti-CD3 was used as
negative controls (dotted line).
The results presented are repre-
sentatives of four experiments.1175 Wang and Lenardo Brief Definitive Report
expression. Interestingly, it has been shown that LFA-1
binding on T cells is transiently activated by TCR stimula-
tion (23). It is possible that TCR engagement during T–B
synapsis transiently upregulates LFA-1 adhesivity on T cells
but LFA-1 on B cells remains inactive.
Since the interactions of LFA-1 and ICAM-1 and
ICAM-2 are important for the lysis of B cells in vitro, we
asked whether they contribute to B cell homeostasis in
vivo. We found no abnormality in the B cell compartment
in relatively young ICAM-12/2 mice (references 24 and 25
and data not shown), but a 30% increase in IgM1 B cells
was consistently observed in the spleens of ICAM-12/2
mice at 6 mo of age as compared with wild type mice (data
not shown). This suggests that B cells accumulate in these
mice with aging. This could be analogous to lpr mice
which gradually develop abnormal B cell accumulation and
autoimmunity depending on the background of the mouse
strain (26). Although difficult to verify experimentally, our
result is consistent with the hypothesis that ICAM-1 is im-
portant for B cell apoptosis mediated by T cells in vivo.
However, no significant production of autoantibodies has
yet been observed in older ICAM-12/2 mice (data not
shown). This could be because autoreactive T cells have
not accumulated in these mice since T cell apoptosis is not
affected by ICAM-1 deficiency (data not shown). An alter-
native explanation is that the ICAM-12/2 mice used here
are on C57BL/6 background which is not prone to au-
toimmunity. ICAM-1 deficiency on autoimmune mouse
backgrounds, such as the MRL strain, might be more ap-
propriate to address such questions.
Figure 5. Resistance to CD41 T cell–mediated lysis by B cells from
ICAM-12/2 mice. Freshly isolated resting B cells and LPS- or anti-
CD40–activated B cells derived from 8-wk-old C57BL/6 ICAM-11/1 or
C57BL/6 ICAM-12/2 mice were labeled with 51Cr. MLR-derived
CD41 CTLs were mixed with the labeled B cells for a 4 h 51Cr-release
assay. The results are representatives of three experiments and were
shown as average of triplicates with standard deviation.
Figure 6. Inhibition of CD41
CTL-mediated lysis of B cells
from C57BL/6 ICAM-12/2
mice by anti–ICAM-2. B cells
derived from C57BL/6 ICAM-
11/1 or ICAM-12/2 mice were
stimulated with LPS and labeled
with 51Cr. MLR-derived CD41
CTLs were mixed with the la-
beled B cells for a 4 h 51Cr-
release assay in the absence or
presence of 5 mg/ml mAbs or
control rat or hamster IgG. The
results are representatives of two
experiments and were shown as
the average of triplicates with
standard deviation.
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